David Einhorn
Greenlight Capital
David Einhorn Chemours Co stake
total: 357
Greenlight Capital CC trades
- Total transactions:
- 26
- New positions:
- 3
- Sold out:
- 3
- Added:
- 6
- Reduced:
- 14
- Held since:
- 2019 Q2
- Held for:
- 13 quarters
- Latest activity:
- 2022 Q3
According to 2026 Q2 report, David Einhorn doesn't hold any Chemours Co (CC) shares. To date, the estimated cost basis is nearly $20.87 for "buy" trades and estimated average "sell" price is $21.46. Greenlight Capital first purchased CC in 2015 Q4, initially acquiring about 3.40M shares. David Einhorn later completely sold out the position and invested in Chemours Co again in 2019 Q2. Since the initial investment in Chemours Co (CC), Greenlight Capital has made 25 more transactions.
When did David Einhorn sell Chemours Co (CC)?
David Einhorn sold off the entire Chemours Co (CC) position in 2022 Q3.
When did David Einhorn buy Chemours Co (CC)?
David Einhorn first invested in Chemours Co (CC) in 2015 Q4 at the reported quarter-end price of $5.36 per share.
What's the cost basis of Greenlight Capital's CC stake?
The estimated cost basis for Chemours Co (CC) stake is around $20.87 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $20.87
- Weighted AVG sell price:
- $21.46
David Einhorn's historical trades in Chemours Co
26 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$32.02
|
|
-100% (-700,000)
|
-1.74%
|
|
2022 Q2
|
1.74%
|
700,000
|
$32.02
|
$22,413,000
|
-67.32% (-1,441,814)
|
-2.93%
|
|
2022 Q1
|
4.28%
|
2,141,814
|
$31.48
|
$67,424,000
|
+22.96% (+400,000)
|
+0.8%
|
|
2021 Q4
|
3.56%
|
1,741,814
|
$33.56
|
$58,456,000
|
-25.00% (-580,605)
|
-1.31%
|
|
2021 Q3
|
4.53%
|
2,322,419
|
$29.06
|
$67,489,000
|
-0.39% (-9,160)
|
-0.02%
|
|
2021 Q2
|
5.09%
|
2,331,579
|
$34.80
|
$81,139,000
|
+4.48% (+100,000)
|
+0.22%
|
|
2021 Q1
|
4.34%
|
2,231,579
|
$27.91
|
$62,284,000
|
-14.08% (-365,670)
|
-0.62%
|
|
2020 Q4
|
3.93%
|
$24.79
|
-14.76% (-449,700)
|
|||
|
2020 Q3
|
5.26%
|
$20.91
|
-10.28% (-349,000)
|
|||
|
2020 Q2
|
5.70%
|
$15.35
|
-30.46% (-1,487,600)
|
|||
|
2020 Q1
|
6.22%
|
$8.87
|
-28.30% (-1,927,194)
|
|||
|
2019 Q4
|
9.14%
|
$18.09
|
+5.05% (+327,402)
|
|||
|
2019 Q3
|
6.97%
|
$14.94
|
+74.20% (+2,761,518)
|
|||
|
2019 Q2
|
6.59%
|
$24.00
|
new
|
|||
|
2019 Q1
|
0.00%
|
$28.22
|
-100% (-200,000)
|
|||
|
2018 Q4
|
0.41%
|
$28.22
|
new
|
|||
|
2018 Q1
|
0.00%
|
$50.06
|
-100% (-1,048,100)
|
|||
|
2017 Q4
|
0.95%
|
$50.06
|
-29.42% (-436,900)
|
|||
|
2017 Q3
|
1.22%
|
$50.61
|
-58.79% (-2,118,070)
|
|||
|
2017 Q2
|
2.20%
|
$37.92
|
-27.94% (-1,396,930)
|
|||
|
2017 Q1
|
2.94%
|
$38.50
|
-44.10% (-3,945,144)
|
|||
|
2016 Q4
|
3.99%
|
$22.09
|
-45.35% (-7,422,042)
|
|||
|
2016 Q3
|
5.01%
|
$16.00
|
-0.26% (-42,700)
|
|||
|
2016 Q2
|
2.48%
|
$8.24
|
+85.58% (+7,567,286)
|
|||
|
2016 Q1
|
1.05%
|
$7.00
|
+160.08% (+5,442,600)
|
|||
|
2015 Q4
|
0.33%
|
$5.36
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.